{"title":"Interplay Between Klotho and IL-6 in Diabetic Kidney Disease: Inflammation, Mineral Dysregulation, and Renal Dysfunction","authors":"Mustafa A. Mahdi, Dhifaf Z. Aziz","doi":"10.1134/S1990750825600396","DOIUrl":null,"url":null,"abstract":"<p>Diabetic kidney disease is a serious complication of diabetes mellitus, often leading to chronic kidney disease and ultimately end-stage renal disease. Inflammation, besides deranged mineral metabolism, plays a role in the pathophysiology of diabetic kidney disease. The present study investigated the relationship between IL-6 an important pro-inflammatory cytokine, and Klotho an anti-aging protein with renoprotective function in diabetic kidney disease progression. A study was carried out on 60 patients with ESRD caused by diabetic kidney disease on maintenance hemodialysis and 40 apparently healthy control individuals. IL-6 and Klotho serum levels were measured using the enzyme-linked immunosorbent assay method. Some biochemical indicators, such as intact parathyroid hormone, 1.25-dihydroxyvitamin D<sub>3</sub>, blood urea, and creatinine, were also measured. The main findings (mean ± SE) showed that the levels of IL-6 and iPTH levels were considerably higher in DKD patients (18.360 ± 2.323 pg/mL; 239.222 ± 24.073 pg/dL) than in controls (4.341 ± 0.393 pg/mL; 26.077 ± 1.609 pg/dL), indicating persistent inflammation and secondary hyperparathyroidism. Conversely, serum 1.25(OH)<sub>2</sub>D<sub>3</sub> and Klotho levels were considerably lower in the DKD group (14.911 ± 0.991 ng/dL and 213.500 ± 25.905 pg/mL, respectively) than in controls (29.125 ± 1.195 ng/dL and 453.587 ± 33.797 pg/mL), indicating kidney function impairment and mineral metabolism disturbance. There was a notable weak inverse relationship between IL-6 and Klotho (<i>r</i> = –0.271, <i>p</i> = 0.036). This suggests that Klotho low levels may increase inflammatory responses and adversely affect renal function. In conclusion, the research demonstrates how IL-6 and Klotho affect one another in diabetic kidney disease. This suggests their application as potential biomarkers for disease progression and targets for therapy in preventing inflammation and maintaining kidney function.</p>","PeriodicalId":485,"journal":{"name":"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry","volume":"20 2","pages":"196 - 210"},"PeriodicalIF":0.4000,"publicationDate":"2026-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry","FirstCategoryId":"2","ListUrlMain":"https://link.springer.com/article/10.1134/S1990750825600396","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Diabetic kidney disease is a serious complication of diabetes mellitus, often leading to chronic kidney disease and ultimately end-stage renal disease. Inflammation, besides deranged mineral metabolism, plays a role in the pathophysiology of diabetic kidney disease. The present study investigated the relationship between IL-6 an important pro-inflammatory cytokine, and Klotho an anti-aging protein with renoprotective function in diabetic kidney disease progression. A study was carried out on 60 patients with ESRD caused by diabetic kidney disease on maintenance hemodialysis and 40 apparently healthy control individuals. IL-6 and Klotho serum levels were measured using the enzyme-linked immunosorbent assay method. Some biochemical indicators, such as intact parathyroid hormone, 1.25-dihydroxyvitamin D3, blood urea, and creatinine, were also measured. The main findings (mean ± SE) showed that the levels of IL-6 and iPTH levels were considerably higher in DKD patients (18.360 ± 2.323 pg/mL; 239.222 ± 24.073 pg/dL) than in controls (4.341 ± 0.393 pg/mL; 26.077 ± 1.609 pg/dL), indicating persistent inflammation and secondary hyperparathyroidism. Conversely, serum 1.25(OH)2D3 and Klotho levels were considerably lower in the DKD group (14.911 ± 0.991 ng/dL and 213.500 ± 25.905 pg/mL, respectively) than in controls (29.125 ± 1.195 ng/dL and 453.587 ± 33.797 pg/mL), indicating kidney function impairment and mineral metabolism disturbance. There was a notable weak inverse relationship between IL-6 and Klotho (r = –0.271, p = 0.036). This suggests that Klotho low levels may increase inflammatory responses and adversely affect renal function. In conclusion, the research demonstrates how IL-6 and Klotho affect one another in diabetic kidney disease. This suggests their application as potential biomarkers for disease progression and targets for therapy in preventing inflammation and maintaining kidney function.
期刊介绍:
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry covers all major aspects of biomedical chemistry and related areas, including proteomics and molecular biology of (patho)physiological processes, biochemistry, neurochemistry, immunochemistry and clinical chemistry, bioinformatics, gene therapy, drug design and delivery, biochemical pharmacology, introduction and advertisement of new (biochemical) methods into experimental and clinical medicine. The journal also publishes review articles. All issues of the journal usually contain solicited reviews.